Financials
- Market Capitalization 24.54 M
- Employee 12
- Founded 2017
- CEO N/A
- Website www.tvarditherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J2QYS9
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4491 | EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -3.17% | -8.41% | +8.54% | -8.13% | 25.44 M USD | ||
| 4501 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.52 USD | -4.55% | -3.82% | +6.33% | +227.27% | 25.15 M USD | ||
| 4510 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.46 USD | +0.69% | +4.29% | +22.69% | +48.98% | 24.34 M USD | ||
| 4512 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.51 USD | -1.18% | -3.09% | -1.18% | -20.06% | 23.72 M USD |